Durham, NC, United States of America

James Martin Lenhard



Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 84(Granted Patents)


Location History:

  • Raleigh, NC (US) (2003 - 2005)
  • Durham, NC (US) (2006 - 2007)
  • Durham County, NC (US) (2006 - 2007)

Company Filing History:


Years Active: 2003-2007

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of James Martin Lenhard

Introduction

James Martin Lenhard is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of diabetes treatment through his innovative patents. With a total of seven patents to his name, Lenhard's work focuses on the development of effective therapies for diabetes mellitus.

Latest Patents

Among his latest patents is a method for the treatment of diabetes mellitus, particularly Type 2 diabetes. This method involves administering a combination of dipeptidyl peptidase IV inhibitors and other antidiabetic agents to mammals in need. Another significant patent involves fluoropyrrolidines as dipeptidyl peptidase inhibitors, which relates to novel compounds that inhibit specific proteases, including DPP-IV, and outlines their therapeutic utility.

Career Highlights

Lenhard is associated with Smithkline Beecham Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and treatment of diabetes, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Lenhard has collaborated with notable colleagues, including Mark Andrew Paulik and Curt Dale Haffner. These collaborations have further enriched his research and innovation efforts.

Conclusion

James Martin Lenhard's contributions to diabetes treatment through his patents highlight his role as a significant inventor in the medical field. His innovative approaches continue to pave the way for advancements in diabetes care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…